These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30529151)

  • 1. The development and characterization of a chemical probe targeting PRMT1 over PRMT5.
    Mann SA; Salsburg A; Causey CP; Knuckley B
    Bioorg Med Chem; 2019 Jan; 27(1):224-229. PubMed ID: 30529151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity, processivity, and kinetic mechanism of protein arginine methyltransferase 5.
    Wang M; Xu RM; Thompson PR
    Biochemistry; 2013 Aug; 52(32):5430-40. PubMed ID: 23866019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
    Fulton MD; Dang T; Brown T; Zheng YG
    Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm.
    Wooderchak WL; Zang T; Zhou ZS; Acuña M; Tahara SM; Hevel JM
    Biochemistry; 2008 Sep; 47(36):9456-66. PubMed ID: 18700728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations.
    Yue Y; Chu Y; Guo H
    Molecules; 2015 May; 20(6):10032-46. PubMed ID: 26035101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide backbone conformation affects the substrate preference of protein arginine methyltransferase I.
    Kölbel K; Ihling C; Kühn U; Neundorf I; Otto S; Stichel J; Robaa D; Beck-Sickinger AG; Sinz A; Wahle E
    Biochemistry; 2012 Jul; 51(27):5463-75. PubMed ID: 22697391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics profiling of arginine methylation defines PRMT5 substrate specificity.
    Musiani D; Bok J; Massignani E; Wu L; Tabaglio T; Ippolito MR; Cuomo A; Ozbek U; Zorgati H; Ghoshdastider U; Robinson RC; Guccione E; Bonaldi T
    Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into protein arginine symmetric dimethylation by PRMT5.
    Sun L; Wang M; Lv Z; Yang N; Liu Y; Bao S; Gong W; Xu RM
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20538-43. PubMed ID: 22143770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic mechanism of protein arginine methyltransferase 1.
    Obianyo O; Osborne TC; Thompson PR
    Biochemistry; 2008 Sep; 47(39):10420-7. PubMed ID: 18771293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-induced control of product formation by protein arginine methyltransferase 1.
    Gui S; Wooderchak-Donahue WL; Zang T; Chen D; Daly MP; Zhou ZS; Hevel JM
    Biochemistry; 2013 Jan; 52(1):199-209. PubMed ID: 23214442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
    Lakowski TM; Frankel A
    Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
    Osborne T; Roska RL; Rajski SR; Thompson PR
    J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein arginine N-methyltransferase 1 (PRMT1) and 2 heteromeric interaction increases PRMT1 enzymatic activity.
    Pak ML; Lakowski TM; Thomas D; Vhuiyan MI; Hüsecken K; Frankel A
    Biochemistry; 2011 Sep; 50(38):8226-40. PubMed ID: 21851090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain.
    Frankel A; Clarke S
    J Biol Chem; 2000 Oct; 275(42):32974-82. PubMed ID: 10931850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptides.
    Thomas D; Koopmans T; Lakowski TM; Kreinin H; Vhuiyan MI; Sedlock SA; Bui JM; Martin NI; Frankel A
    Chembiochem; 2014 Jul; 15(11):1607-13. PubMed ID: 25044481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues.
    Zurita-Lopez CI; Sandberg T; Kelly R; Clarke SG
    J Biol Chem; 2012 Mar; 287(11):7859-70. PubMed ID: 22241471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
    Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
    ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
    Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
    Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems.
    Wang YC; Li C
    FEBS J; 2012 Mar; 279(6):932-45. PubMed ID: 22251447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.